University of Vermont

UVM ScholarWorks
UVM Honors College Senior Theses

Undergraduate Theses

2014

Explaining Hospital Length of Stay of Patients Admitted with
Seasonal Influenza Infection
Anna B. Lidofsky
University of Vermont

Follow this and additional works at: https://scholarworks.uvm.edu/hcoltheses

Recommended Citation
Lidofsky, Anna B., "Explaining Hospital Length of Stay of Patients Admitted with Seasonal Influenza
Infection" (2014). UVM Honors College Senior Theses. 43.
https://scholarworks.uvm.edu/hcoltheses/43

This Honors College Thesis is brought to you for free and open access by the Undergraduate Theses at UVM
ScholarWorks. It has been accepted for inclusion in UVM Honors College Senior Theses by an authorized
administrator of UVM ScholarWorks. For more information, please contact scholarworks@uvm.edu.

Explaining Hospital Length of Stay of Patients
Admitted with Seasonal Influenza Infection
Anna Lidofsky
University of Vermont Department of Microbiology & Molecular Genetics
201 Stafford Hall, 95 Carrigan Drive, Burlington, VT 05405
Background: The annual occurrence of seasonal influenza virus poses a significant
health burden worldwide. There is evidence that certain populations are more at risk for
influenza infection, such as cigarette smokers, the elderly, and patients with
cardiopulmonary disorders. In some cases influenza virus presents itself as a nosocomially
acquired infection. Thus, monitoring the length of time that patients are hospitalized with
influenza is of clinical importance.1 The objectives of this study were to indentify
predisposing characteristics to hospitalization with influenza and to determine whether
cigarette smoking correlates to extended LOS (length of stay in hospital). It was
hypothesized that cigarette smoking and presence of COPD (Chronic Obstructive
Pulmonary Disease) correlates most significantly to prolonged LOS.
Methods: After ethical approval was achieved from the University of Vermont
Institutional Review Board, information was collected from a retrospective cohort of adult
patients admitted to FAHC (Fletcher Allen Health Care) with influenza infection during
the 2012-2013 flu season. Univariate analyses were performed to compare explanatory
variables with LOS as an outcome. A generalized linear model was constructed to further
explain correlations with LOS.
Results: Among 54 patients, the median age was 73.5 and the median BMI (Body Mass
Index) was 26.1 kg/m2. The cohort was split almost equally between males and females
and exactly two-thirds were smokers, with just under one-third of the patients diagnosed
with COPD. Univariate analyses determined that patients with COPD, diabetes, and
more than one comorbid condition significantly increased LOS (p = 0.0129*, 0.0191*,
0.0046*; respectively). A generalized linear model revealed that patients with COPD and
more than one comorbid condition were estimated have a significantly prolonged LOS (p
= 0.0266* and 0.0079*, respectively). Smoking status was not determined to be a
significant explanatory variable in either set of analysis.
Conclusions: Significant indicators for lengthier LOS are explained by diagnosis of
COPD and patients with more than one comorbidity. Promoting the use of vaccination
for these at-risk individuals is imperative, as influenza infection is a serious issue.
and mortality.2, 3 Epidemics of influenza
occur annually in the temperate zones
during the winter months.2, 3
Influenza viruses are segmented, negativesense, double-stranded RNA viruses.2

One of the most common disease
syndromes in humans are viral infections
of the respiratory tract, and of these
viruses, influenza viruses are one of the
more significant causes of high morbidity
1

Some viral particles contain envelope
proteins, which increase virulence through
three transmembrane proteins: HA
(hemagglutinin), NA (neuraminidase), and
M2, an ion channel facilitator. HA
provides the receptor-binding site for
viral-antibody neutralization, an essential
function for virus infectivity. Removal of
sialic acid, the cell surface receptor for
influenza, a process that is aided by NA,
allows for release of viral particles from
the cell surface and viral spread. The ion
channel is crucial during the uncoating
process of the virus.2
The arrangements of surface
glycoproteins on HA and NA determine
variable subtypes of influenza viruses.2
Because influenza virus is segmented,
many arrangements are possible and
explains the continual appearance of new
antigenic strains of influenza, as well as
accounting for the occurrence of historical
pandemics and yearly epidemics.2, 3 The
evolution of new strains of viruses arises
through antigenic drift and antigenic shift,
which is characterized by point mutations
in the surface glycoproteins of HA.2
Influenza types A and B are the
main human pathogens.2 Of the recently
circulating influenza viruses, the H3N2
strain of influenza A is the most virulent.2
The aptitude of influenza virus to mutate
explains its severe impact on humans in
terms of morbidity and mortality, relative
to respiratory viruses.2
Influenza can cause a broad range
of illness, ranging from symptomless
infection to onset primary viral
pneumonia and secondary bacterial
pneumonia.2 In its full form, influenza is
an acute respiratory disease characterized
by high fever, cough, headache, and
inflammation of the upper respiratory tree

and trachea. Symptoms typically persist
for seven to ten days.3
The severity of viral illness is highly
dependent on the particular virus and host
factors. Much of the detrimental effects
from influenza virus are concentrated in
high-risk groups. These include cigarette
smokers, the elderly, and those with
comorbid cardiovascular and pulmonary
disease.2
Cigarette Smoking: A Risk Factor for Influenza
Infection
According to researchers from the
University of California San Francisco,
infectious diseases could rival the usual
suspects of sources of morbidity and
mortality associated with smoking
cigarettes, such as heart disease, cancer,
and chronic lung disease.4 Indeed, there is
increasing evidence that smokers are more
susceptible to respiratory viral infections,
although the mechanisms that mediate
these effects are still being investigated.
Cigarette smoke is a heterogeneous,
complex mixture, containing over 4,700
chemical compounds and oxidants. These
chemical agents induce an oxidative
burden on the body, causing disruptions
in normal mechanisms of cellular signaling
that can lead to cellular damage of the
lungs, specifically the alveolar wall, which
leads to airway enlargement.5
Oxidative stress on the lungs can
also result in loss of mucociliary function
in the respiratory tract. It is likely that this
loss of function contributes to an increased
risk of microbial infection in smokers by
reducing the ability of the respiratory tract
to clear pathogens.6
A research team from the
University of North Carolina Chapel
2

created an in vitro model of differentiated
nasal epithelial cells from smokers (which
emulates many characteristics of airway
epithelium in vivo) in order to determine
how the immune response elicited by
epithelial cells contributes to the enhanced
susceptibility of smokers. Results indicated
that the immune response to influenza for
smokers is significantly downregulated in
comparison with nonsmokers.7
These findings were confirmed in
vivo, in a study in which human volunteers
(smokers and non-smokers) were
inoculated nasally with live-attenuated
influenza virus vaccine.7
One group of researchers looked to
establish links between influenza virus and
cigarette smoke using a mouse model.
The team demonstrated the effects of
cigarette smoke on alterations to innate
immunity, specifically with PAMP(pathogen-associated molecular pattern)
induced pulmonary inflammation and
remodeling in mice.8 It was demonstrated
that cigarette smoke selectively enhances
responses already induced in the murine
lung by influenza virus and viral PAMPs,
such as airway and alveolar inflammation
and remodeling.8
Importantly, it was shown that
cigarette smoke and a synthetic analog of
influenza virus interacted synergistically to
enhance BAL (bronchoalveolar lavage)
total cell recovery, airway, and alveolar
inflammation. BAL is a technique often
used in immunological research as a way
to sample components of the epithelial
lining fluid and to determine pathogen
levels in the lung. It was also found that
cigarette smoke selectively enhanced the
ability of influenza analog to induce
pulmonary emphysema and airway
remodeling.8

Other experiments by these
researchers demonstrated that this
synergism relies on a specific molecular
pathway involving a mitochondrial
antiviral signaling protein, cytokines, and
an RNA-dependent protein kinase. This
pathway revealed that molecular facets of
cigarette smoke could injure the lungs
significantly enough to promote
emphysema.8 The process of alveolar
destruction is also thought to course with
an imbalance between matrix protease
and antiproteases, favoring the breakdown
of extracellular matrix proteins.8, 9
COPD Exacerbations and Viral Infection
The leading cause of COPD
(Chronic Obstructive Pulmonary Disease)
is smoking cigarettes. It is estimated that
COPD affects 43 million people and is the
fourth leading cause of morbidity and
mortality in the United States. By 2020,
COPD is estimated to become the fifth
leading cause of death worldwide.10
Acute exacerbations account for
much of the morbidity and mortality
associated with COPD, which result in
patients having extreme difficulty in
breathing.10 Infection of the
tracheobronchial tree, the structure that
forms the airways that supply air to the
lungs, is the most common cause of
COPD exacerbations.2
A study was conducted among
patients hospitalized with acute
respiratory disease during an influenza
epidemic, and it was determined that
COPD was the most common underlying
disease, suggesting that pulmonary disease
is a significant risk factor for adverse
outcome with influenza infection.11
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Direct studies of viral infections in
COPD exacerbations suggest that there is
an association of influenza with COPD.
These studies have utilized modern
diagnostic methods such as polymerase
chain reaction (PCR) to detect virusassociated exacerbations.12, 13,14
The burden of COPD is
proportionately greater in the elderly.2 A
number of respiratory societies have
published national or international
guidelines for the optimal management of
COPD, which generally recommend
universal administration of annual
influenza vaccination.10 It should be
noted that there is evidence that
vaccination is not necessarily effective at
reducing hospitalization in patients with
COPD, indicating that there could be a
reduction in the efficacy of vaccination
against influenza in patients diagnosed
with COPD.15

smokers.16, 17 Adults 65 and older smoke at
significantly lower rates than those in
other age groups. Less than 62% of
Vermont adult smokers made attempts to
quit smoking in 2012, greater than the
nationally reported value of 59% seen
among all adults in the United States.
Quit attempts are highest among the 1824 age group.16 This study did not report
information about the specific smoking
histories of adults over the age of 65.
2012-2013 Influenza Season
The 2012-2013 influenza season
had an early start. Influenza activity in
the United States peaked four weeks
earlier in comparison to recent seasons.
This jump-started a strenuous year
characterized by more infection than
usual.18
A striking outcome from the 20122013 season was the ineffectiveness of a
vaccine against strain A/H3N2 in the
elderly population. A study of vaccine
inefficacy suggested that an antigenic shift
could not sufficiently explain this
observation, as the vaccine in younger
populations was shown to elicit a normal
immune response.19
A proposed interpretation of this
outcome is that elderly populations
generate a narrow antibody response to
the vaccine strain of H3N2, incapable of
protecting against H3N2 virus with shifted
antigenicity.19 Other studies show
evidence of an increase in influenzaattributable mortality rates among persons
aged 65 years or older.20
There is also an indication that
older individuals who were vaccinated
against influenza in 2012 were not
necessarily fully protected. In an article

Prevalence of Smoking and COPD Among
Vermonters
A 2012 report conducted by the
Behavioral Risk Factor Surveillance
System of the Vermont Department of
Health investigated the prevalence risk
factors and behaviors throughout the
state. It was determined that 6% of
Vermont adults have been diagnosed with
COPD.16
Adults 65 and older have
significantly higher rates of COPD than
all other age groups, suggesting that the
prevalence of COPD increases as
Vermonters age.16
Only 17% of Vermonters reported
being cigarette smokers in 2012, a value
slightly lower than the national statistic of
18.1% among U.S. adults being cigarette
4

published in the Morbidity and Mortality
Weekly Report by the Centers for Disease
Control, vaccine effectiveness was
reported to be 32.0% in the age group of
> 65 years, with 17.1% of this age group
prevented against hospitalization with
influenza due to the vaccine.21

Allen Health Care), was the source of data
for this study. FAHC serves a population of
greater than 1 million individuals in
Vermont and northern New York.23 The
hospital is based in Burlington, Vermont
and provides a full range of tertiary-level
inpatient and outpatient services.

Objectives of Study

Data Preparation, Collection, and Management

Nosocomial infections are hospitalacquired infections. As influenza virus is
considerably contagious through airborne
transmission and has a better chance of
infectivity due to its ability to easily
mutate, it can present itself as a
nosocomial infection.1, 2
LOS (length of stay in hospital)
measures the number of days that a
patient will spend in the hospital. Shorter
lengths of stay indicate more efficient and
effective care, and usually, a better
outcome for the patient.22 Moreover,
shorter lengths of stay reduce the spread of
unwanted nosocomial infections, like
influenza.
This study is an epidemiological
retrospective investigation seeking to
determine which patient characteristics
explained prolonged LOS, given
admittance to hospital with influenza
infection. It was hypothesized that
increased LOS due to influenza infection
would significantly correlate with a
patient’s smoking status and COPD
condition.

Inclusion criteria were established
to incorporate any patient at least 18 years
old that was admitted for at least one night
between October 1, 2012 and June 1,
2013 with influenza infection as a primary
reason for hospital admission, with
confirmation from the Fletcher Allen
Laboratory of presence of influenza viral
infection. After ethical approval was
granted from the University of Vermont
Institutional Review Board, the data set
was accessed. The following data was
recorded into an Excel spreadsheet:
• Age
• Sex
• Height
• Weight
• Viral strain
• Current smoking status
• Presence of smoking history
• Presence of cardiac disease
• Presence of kidney disease
• Presence of cancer
• Presence of diabetes
• Presence of COPD
All data was copied from Microsoft
Excel into a spreadsheet for statistical
analysis by JMP Pro version 10.0.
Cardiac disease is a broad umbrella
term with multiple definitions.24 For the
purposes of this study, patients were
defined as diagnosed with cardiac disease

METHODS
Study Area and Data Source
PRISM, the hospital administrative
database employed by FAHC (Fletcher
5

if any of the following syndromes were
included in their charts:
• Coronary artery disease
• Coronary atherosclerosis
• Congestive heart failure
• Primary hypertrophic
cardiomyopathy
• Non-ST elevation myocardial
infarction
• Acute coronary syndrome
• Diastolic heart failure
All the explanatory variables are
characteristics possessed by the patient
prior to admission and did not change
over the course of the hospital stay. If
patients died in hospital, they were
excluded from analysis, as LOS no longer
would adequately explain extent of
morbidity from influenza infection.

sum of the third quartile and the IQR
(interquartile range) multiplied by 1.5.26
Log transformation of data is also
recommended, as it is known to generate a
near normal distribution.26 A KolmogrovSmirnov test was run after outlier analysis
to assess the goodness of fit of LOS to a
log-normal distribution.27
Descriptive statistics
After outlier analysis, categorical
and quantitative distributions were
analyzed for
• Age
• Sex
• Comorbidities
• Viral strain
• Smoking status
• BMI (Body Mass Index categories
shown in Table 1, page 12)
• Date admitted
• Hospital floor where the patient
was initially admitted.
Median and IQR were noted for
continuous data, as distributions followed
non-normal curves, and different
proportions were noted for categorical
data.

Outlier Analysis: LOS is “bedeviled by the
presence of outliers” 26
To calculate hospital LOS, the date
the patient was initially admitted to
FAHC was subtracted from the date the
patient was discharged. Outliers,
normally those of unusually lengthy stays
that are extremely variable in length and
occurrence, often characterize the
distribution of LOS in hospital, resulting
in a skewed, non-normal distribution of
LOS.25, 26
The issue with incorporating
outliers into analysis is the
disproportionate effects they have when
developing models for explaining LOS.
Efforts have been made to develop
accurate and consistent statistical methods
for analyzing outliers of LOS distribution.
Current recommendations suggest that
exclusion of outliers be accomplished by
defining the maximum cut-off point as the

Non-Parametric Univariate Statistical Analyses
Wilcoxon signed-rank tests were
utilized as nonparametric significance tests
to compare LOS to patient
characteristics.27, 28 Because a leading
cause of COPD is smoking, a Fisher’s
exact probability test was performed to
determine whether smoking status was
independent of COPD status.28
Choosing a Generalized Linear Model to Explain
LOS
6

was chosen, as it is indicative of a good
model.30

It is argued that when modeling
LOS the purpose of the analysis must be
seriously considered.29 Indeed, “the
significance of the association between
length of stay and patient characteristics,
as reported in the clinical literature, is due
in part to the statistical model chosen.”29
Because this study has a descriptive
purpose, with an emphasis placed on
explaining LOS as a result of patient
characteristics, a generalized linear model
was thus constructed to relate factors
associated with patient LOS as the
response variable.
The number of days each patient
stayed at the hospital is recorded as a
count.30 As a consequence, the Poisson
regression model is particularly
appropriate when LOS is used as a
response variable.30 A random variable
will have Poisson distribution mean (µ) set
equal to the variance of the distribution,
meaning that any factor that affects one
will also affect the other.31
A measure of discrepancy between
observed and fitted values is the deviance.
This deviance can be measured using
Pearson’s chi-squared statistic in the same
form as it would be used for binomial
data.31
For this study, the most
representative model was picked by
confirmation of good fit. The expected
value of a chi-squared random variable is
equal to its dF (degrees of freedom);
meaning, the closer to 1 the ratio of the
chi-squared expected value to dF is, the
better the fit of the model.30 An additional
fit statistic that was utilized was the fitted
Akaike Information Criterion (AICc).
The model with the lowest AICc value

RESULTS
After reviewing the distribution of
LOS, outliers were cut out as
recommended by the literature.26 This
resulted in outliers being defined as any
patient staying 14 days or longer. LOS
data was log transformed after outlier
analysis to assess the distribution’s
normality, as shown in Figure 1 (page 13).
The data did not follow a log normal
distribution after outlier analysis, as the
Kolmogrov-Smirnov test confirmed in
Table 2 (page 14). Descriptions of the six
outliers are presented in Table 3 (page 15).
Descriptive Statistical Analyses
As Table 4 depicts (page 16), the
most common comorbidity associated
with the group is cardiac disease (n = 27;
50.0%), followed by kidney disease (n =
18, 33.3%), and equal prevalence of
COPD and diabetes (n = 16, 29.6%).
Cancer is only present in eight patients
(14.8%). Of the 54 patients included after
outlier analysis, 48.1% of the patients have
two or more of the observed comorbidities
(n = 26).
The distribution of sex is split
almost equally, with 28 females and 26
males. As expected for a group of
hospitalized adult patients infected with
influenza in the 2012-2013 season, the
cohort is predominately representative of
an elderly population.30 Thus, the age
distribution is skewed to the right, with a
median age of 73.5. The youngest patient
is 36 years old and the oldest patient is 95
years old.
7

The group is predominantly
diagnosed with Seasonal H-3 Influenza A
virus, with 64.8% of patients with cultures
positive (n = 35). 22.2% of the group has
Influenza A virus (n = 12) and 13.0% of
the group had Influenza B virus (n = 7).
Information about height and
weight was missing in the charts for two
patients, but for the rest of the group,
60.7% of the patients classify as either
obese or overweight (n = 31), in
accordance with BMI standards (Table 1,
page 12). 38.4% of the group is classified
with a normal BMI (n = 20), and only one
patient is categorized as underweight.
The median BMI is 26.1, overweight.
Information about smoking histories was
missing in the charts for three patients.
Exactly two-thirds of the rest of the group
were designated as smokers (n = 34,
66.7%). One-third of the patients were
initially admitted to Baird 4, the Medicine
unit of FAHC (n = 18, 33.3%). The
distribution of the months when patients
first were admitted was also observed.
Almost three-quarters of the patients were
admitted in January (n = 28, 51.9%) or
December (n = 11, 20.3%).

Extent of comorbidities was coded
as “A” (presence of 1 or 0 comorbid
conditions) or “B” (presence of 2-5
comorbid conditions).
It was also determined that the
probability of being a smoker was
significantly greater for patients diagnosed
with COPD (p = 0.0047*), according to a
Fisher’s Exact test as displayed in Table 6
(page 18).
Generalized Linear Model: COPD and Extent of
Comorbidities Significantly Explain LOS
50 patients were included in the
construction of a generalized linear model
fit, which was generated to determine
what factors influencing LOS due to
influenza infection could be deemed as
independent explanations. Factors that
were included in the model were standard
demographic information (Age, Sex,
BMI), smoking status, cardiac disease,
diabetes, COPD, and extent of
comorbidities (A or B).
Table 7 (page 19) displays multiple
tests for goodness of fit, including Pearson
and Deviance chi-square to dF ratios, and
AICc values.
Finally, Table 8 (page 20)
summarizes the parameter estimates from
the generalized linear model. Patients
without COPD and 1 or less comorbidities
were estimated to significantly stay less (p
= 0.0266* and 0.0079*, respectively).
Smoking status, however, was not a
significant explanatory value.

Univariate Analyses
Wilcoxon tests were performed for
linear regression and one-way ANOVA
univarate analyses, comparing one patient
characteristic as an explanatory variable
to LOS as the response variable. Table 5
(page 17) displays explanatory variables
that significantly explained longer LOS.
These included diabetes, COPD and
having two or more comorbidities (p =
0.0191*, 0.0129*, and 0.0046*;
respectively). Smoking did not
significantly explain longer LOS.

DISCUSSION
Significance of COPD and Extensiveness of
Comorbidities: Why not Smoking Status?

8

The major findings of this study
imply that COPD and patients with
extensive comorbid conditions that are
admitted to the hospital for influenza are
estimated to stay longer in the hospital.
These results are in accordance with
clinical wisdom, considering that LOS is
to an extent a measure of burden of
disease.22
However, part of the initial
hypothesis cannot be fully confirmed,
which was the idea that smoking status
would indirectly correlate with prolonged
LOS. The underlying basis for the
proposed hypothesis was the plethora of
literature discussing the synergistic effects
of cigarette smoking and viral infection,
specifically influenza.4-9, 32 Yet univariate
and multivariate analysis with smoking
status as an explanatory variable did not
significantly explain longer stays in
hospital. There are two possible
explanations why the hypothesis was not
confirmed.
First, smoking status was defined in
a broad sense. Smokers were designated
as any patients with any form of smoking
history (including new smokers, light
smokers, heavy smokers, current nonsmokers with history of smoking). Ideally,
patients would have been categorized into
different levels of smoking status, but
unfortunately, there was not enough
information about pack-years in the
patient charts to determine extent of
smoking history. It is suggested in the
literature that repeated use of cigarettes
could lead to worsened susceptibility to
influenza infection, relative to lighter
exposure to cigarette smoke.32 This
finding implies that patients who have a
heavier smoking history could be more
susceptible to lengthier stays in hospital.

Moreover, one study determined that after
six weeks of smoking cessation, patients
regained significant functionalities in
adaptive immune response.32 The general
way in which smoking status was assigned
for this study was unlikely able to account
for these variables.
Given the significant correlation of
COPD to smoking status (Table 6, page
18), COPD could be considered a marker
of the burden of heavy smoking. And as
shown in Table 4 (page 16) a majority of
the subjects designated as smokers in the
study did not have COPD (55.9%),
indicating that there might have been a
wide range of levels of smoking usage in
subjects designated as smokers. This
implies that specifically heavy smoking,
not just any general exposure to smoking,
could be associated with prolonged LOS.
A second possible reason
explaining why smoking status did not
associate with extended LOS is that
models were too underpowered to
adequately address the issue of smoking.
As depicted in Table 4 (page 16), a
majority of the cohort were smokers
(66.7%, n = 34). The sample size of nonsmokers was consequently rather small,
resulting in a plausible power issue in the
model.
Cardiac Disease: An Anomaly in the Model
In the generalized linear model,
absence of cardiac disease was almost
significant as an explanatory factor of
increased LOS due to flu infection (p =
0.0562). This finding is peculiar because
cardiac diseases are associated among risk
factors for influenza infection.2 A potential
explanation for this outcome could be that
preferential treatment is given to patients
9

with cardiac conditions by clinicians.
However, there is no evidence to support
this speculation in the literature, so this
result is puzzling.

A further limitation of this study is
that COPD is commonly misdiagnosed.35
A final thought worth mentioning is that,
given the high prevalence of elderly
patients in the cohort’s age distribution,
this investigation can be considered a
geriatric study of sorts. There is a
potential for a multitude of external biases,
such as frailty, which is a significantly
weakened state due to the cumulative
decline over an individual’s lifetime of
multiple physiological systems.36

Modeling Bias and Other Limitations
Identifying the causes of a health
outcome, such as LOS in an uncontrolled
environment, is problematic because of
the high prevalence of modeling bias.33
Model overfit, or more commonly,
underfit, can lead to severely invalid
conclusions due to confounding between
relevant covariates or between covariates
and casual variables.33 A plethora of
potential significant explanatory values
that were not included in this study may
better explain extended LOS due to
infection with influenza.
In retrospective studies such as this
one, correlation does not imply causation.
Ideally, it is recommended that future
controlled experiments be conducted to
confirm suspicions of COPD and
extensive comorbidities by establishing
causal relationships between explanatory
variables and the health end point, LOS.33
In the context of this study, however,
controlled experiments explaining LOS
due to influenza infection may be difficult
to construct.
Additionally, to reduce potential
confounding between comorbidities, it is
suggested in the literature to utilize
comorbidity scores as a way to rank the
severity of additional complications.34
Further studies could also try to account
for the patients with cardiac disease,
perhaps categorizing different cardiac
disease syndromes and ranking them, as
this was an unusual finding from the linear
model.

CONCLUSIONS
It is an important finding that LOS
of patients hospitalized with influenza is
estimated to be lengthier in patients with
COPD and multiple comorbid conditions.
Targeting these high-risk individuals for
vaccination may reduce the burden of
hospitalization and nosocomial risk.
Indeed, these findings support current
recommendations for emphasis of
populations that should be vaccinated.37
Insufficient evidence of vaccination
in the charts excluded the possibility of
accounting for vaccination histories of
subjects. It could be that there is a limited
adherence to vaccine standards in
Vermont and northern New York,
especially for at-risk populations. Further
studies are necessary to validate this
speculation.
With a burdensome infectious
disease such as influenza, it is imperative
to construct measures to reduce LOS to a
minimum. The benefits include reduced
costs, enhance quality of life for patients,
an improvement in the utilization of
resources and a reduction in the risk of
viral transmission to other patients in the
hospital.
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Table 1
Body Mass Index Classifications
Category

BMI (kg/m2)

Underweight

<18.5

Normal

18.5-24.9

Overweight

25.0-29.9

Obesity, Class I

30.0-34.9

Obesity, Class II

35.0-39.9

Extreme Obesity, Class III
> 40
Note. Adapted from “Preventing and Managing the
Global Epidemic of Obesity. Report of the World
Health Organization Consultation of Obesity.”
WHO, Geneva, June 1997.26

12

Figure 1
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Note. LOS Distribution, fitted log-normal.
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Table 2
Kolomogorov-Smirnov Goodness of Fit
Test Statistic (D)
P
0.1349

0.0211*

Note. Null hypothesis = the data is from Log
Normal distribution. Small p-values reject null
hypothesis. α = 0.05. Significant at P < 0.05.

14

Table 3
Profiles of the Outliers
Patient Identification

LOS

Comments

V06

20 days

73-year-old female, nonsmoker with cardiac disease,
COPD, and diabetes

V07

65 days

67-year-old borderline
overweight male, former
smoker (105 pack years),
cardiac disease and diabetes

V11

19 days

64-year-old overweight male,
former smoker (168 pack
years), cardiac disease and
COPD

V12

14 days

59-year-old male, former
smoker (60 pack years),
COPD

V25

14 days

97-year-old female, nonsmoker with cardiac disease

V64

21 days

57-year-old female, former
smoker (3 pack years),
kidney disease and diabetes
Note. Six outliers were excluded from the study.
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Table 4
General Characteristics of Patient Cohort
Demographic
Gender
Female
BMI Category*
Underweight
Normal
Overweight
Obesity, Class I
Obesity, Class II
Obesity, Class III

n (%)

Demographic

28 (51.9)

1 (1.9)
20 (38.4)
16 (30.8)
4 (7.7)
4 (7.7)
7 (13.5)

Viral Strain
A
B
Seasonal H3A

12 (22.2)
7 (13.0)
35 (64.8)

Comorbidities
Cardiac Disease
Kidney Disease
COPD
Diabetes
Cancer
> 2 of the above

27 (50.0)
18 (33.3)
16 (29.6)
16 (29.6)
8 (14.8)
26 (48.1)

Demographic

Median (IQR)

Age

73.5 (20.5)

BMI*

26.1 (8.3)

n (%)

Smoking Status*
Smoker
COPD in Smokers

34 (66.7)
15 (44.1)

Month Admitted
December
January
February
March
April
May

11 (20.3)
28 (51.9)
9 (16.7)
1 (1.9)
3 (5.5)
2 (3.7)

Floor Initially Admitted To
Medicine
Cardiology
Orthopedics
Cardiothoracic
Medical ICU
Neurology
General Surgery
Surgical ICU
Emergency

18 (33.3)
11 (20.3)
7 (13.0)
7 (13.0)
4 (7.4)
3 (5.5)
2 (3.7)
1 (1.9)
1 (1.9)

LOS
4 (4.0)
Note. * = Total n ≠54 for these patients; information missing from charts
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Table 5
Indicators of Significant Extension of LOS
Explanatory
ChiSquare
dF
P
Variable
Diabetes

5.4927

1

0.0191*

COPD

6.1888

1

0.0129*

>2 Comorbidities

8.0387

1

0.0046*

Note. Univariate analyses conducted at α =
0.05. Significant at P < 0.05. Wilcoxon;
Pearson’s ChiSquare Test.

17

Table 6
Fisher’s Exact Test
Test
P

Alternative Hypothesis

Left

0.9997

P (Smoking Status =
Smoker) is greater for
absence of COPD

Right

0.0047*

P (Smoking Status =
Smoker) is greater for
presence of COPD

2-Tail

0.0089*

P (Smoking Status =
Smoker) is different
across COPD

Note. n = 51, α = 0.05
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Table 7
Goodness of Fit
Fit Statistic ChiSquare dF

ChiSq:dF ratio

P

Pearson

52.9536

41

1.2916

0.0999

Deviance

48.4508

41

1.1817

0.1976

AICc
236.15
Note. The closer the ChiSquare:dF ratio is to 1, the better
the fit. Smaller AICc indicates a better fit30
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Table 8
Parameter Estimates from Generalized Linear Model
Term

Estimate

Std Error dF

ChiSquare

P

Confidence Interval

Intercept

1.5875

0.5054

1

9.4329

0.0021*

0.5831 to 2.5661

Age

-4.1e-6

0.0052

1

6.41e-7

0.9994

-0.010 to 0.0102

Female

0.0535

0.0729

1

0.5388

0.4629

-0.0894 to 0.1965

BMI

0.0005

0.0090

1

0.0029

0.9567

-0.0174 to 0.0179

Non-smoker

-0.0188

0.0883

1

0.0456

0.8310

-0.1940 to 0.1528

Absence of
Cardiac
Disease

0.1538

0.0803

1

3.6458

0.0562

-0.0041 to 0.3109

Absence of
Diabetes

-0.0742

0.0780

1

0.9053

0.3414

-0.2268 to 0.0789

Absence of
COPD

-0.1693

0.0760

1

4.9163

0.0266*

-0.3181 to -0.0198

<1
Comorbidity

-0.2416

0.0906

1

7.0593

0.0079*

-0.4193 to -0.0636

Note. n =50, α = 0.05, Generalized linear model, log-link function with Poisson
distribution.
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